Arformoterol Oral Inhalation
Explore these free sample topics:
-- The first section of this topic is shown below --
(ar'' for moe' ter ol)
In a large clinical study, more people who used an asthma medication similar to arformoterol experienced more severe episodes of asthma that needed to be treated in a hospital or caused death than patients who did not use the medication. Use of arformoterol inhalation may increase the risk of serious asthma problems or death in people who have asthma. Arformoterol has not been approved by the Food and Drug Administration (FDA) to treat asthma. There is not enough information to tell whether arformoterol increases the risk of death in people who have chronic obstructive pulmonary disease (COPD; a group of lung diseases, which includes chronic bronchitis and emphysema).
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with arformoterol and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.
Talk to your doctor about the risks of using arformoterol inhalation.